Guangdong VTR Bio-Tech Co Ltd (300381) — Strategic Asset Allocation Index
Guangdong VTR Bio-Tech Co Ltd (300381) has a Strategic Asset Allocation Index of 27.2% as of June 2023. Strategic assets (PP&E of CN¥758.56 Million plus long-term investments of CN¥-) total CN¥758.56 Million, measured against net assets of CN¥2.79 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Guangdong VTR Bio-Tech Co Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Guangdong VTR Bio-Tech Co Ltd Strategic Asset Allocation Index (2010–2022)
This chart shows how Guangdong VTR Bio-Tech Co Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2010 to 2022. As of June 2023, the index stands at 27.2%, representing strategic assets of CN¥758.56 Million against net assets of CN¥2.79 Billion CNY. For live market cap and overall valuation, see 300381 market cap overview.
Annual Strategic Asset Allocation Index for Guangdong VTR Bio-Tech Co Ltd (2010–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Guangdong VTR Bio-Tech Co Ltd from 2010 to 2022, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Guangdong VTR Bio-Tech Co Ltd net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 25.2% | CN¥708.22 Million | CN¥708.22 Million | CN¥- | CN¥2.82 Billion | ▼ -27.4 pp |
| 2021 | 52.6% | CN¥1.60 Billion | CN¥1.60 Billion | CN¥- | CN¥3.05 Billion | ▲ +3.2 pp |
| 2020 | 49.3% | CN¥1.61 Billion | CN¥1.61 Billion | CN¥- | CN¥3.26 Billion | ▼ -7.7 pp |
| 2019 | 57.1% | CN¥1.56 Billion | CN¥1.56 Billion | CN¥- | CN¥2.73 Billion | ▲ +1.4 pp |
| 2018 | 55.6% | CN¥1.34 Billion | CN¥1.33 Billion | CN¥6.98 Million | CN¥2.41 Billion | ▼ -1.0 pp |
| 2017 | 56.6% | CN¥1.18 Billion | CN¥1.18 Billion | CN¥3.00 Million | CN¥2.09 Billion | ▲ +9.6 pp |
| 2016 | 47.0% | CN¥965.97 Million | CN¥962.97 Million | CN¥3.00 Million | CN¥2.05 Billion | ▼ -8.9 pp |
| 2015 | 55.9% | CN¥791.12 Million | CN¥788.12 Million | CN¥3.00 Million | CN¥1.42 Billion | ▲ +6.3 pp |
| 2014 | 49.6% | CN¥340.05 Million | CN¥340.05 Million | CN¥- | CN¥685.38 Million | ▼ -8.7 pp |
| 2013 | 58.4% | CN¥178.43 Million | CN¥178.43 Million | CN¥- | CN¥305.76 Million | ▲ +11.2 pp |
| 2012 | 47.1% | CN¥114.37 Million | CN¥114.37 Million | CN¥- | CN¥242.72 Million | ▲ +0.1 pp |
| 2011 | 47.0% | CN¥88.36 Million | CN¥88.36 Million | CN¥- | CN¥188.00 Million | ▼ -10.3 pp |
| 2010 | 57.3% | CN¥83.02 Million | CN¥83.02 Million | CN¥- | CN¥144.81 Million | — |